# AdhexPharma acquires tesa Labtec from tesa SE

AdhexPharma acquired 100% of the shares in tesa Labtec GmbH from tesa SE. tesa Labtec is a CDMO offering formulation, development, and contract manufacturing of transdermal and topical patches and films. Terms were not disclosed.

- Type: Acquisition
- Announced: 2022-10-05
- Where: Langenfeld and Hamburg, Germany
- Status: completed
- Products: transdermal patches, oral thin films, topical patches, buccal films, sublingual films
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Tesa SE](https://endata.com/companies/32064.md) (partner)
- [AdhexPharma](https://endata.com/companies/65752.md) (acquirer)
- [tesa Labtec](https://endata.com/companies/65753.md) (target)

## Sources

- [milbank.com](https://www.milbank.com/en/news/milbank-advises-adhexpharma-on-acquisition-of-tesa-labtec.html), 2022-10-05: "With this acquisition, AdhexPharma joins forces with tesa Labtec, a well-known CDMO company offering formulation, development, and contract manufacturing services of transdermal and topical patches as well as buccal and sublingual films."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.